Medikan Co., Ltd.

Cell Surgical Network (CSN) is a global physician-led network operating across 500+ doctors at 125+ locations in 25 countries, specializing in autologous adipose-derived stem cell (SVF) therapy for regenerative medicine. The network provides investigational personal cell therapy protocols for orthopedic, neurological, cardiac, and systemic conditions. CSN operates the Regenatrak Database—a HIPAA-compliant outcome tracking platform documenting 25,000+ cell deployments and safety data from nearly 1,700 cases. The company offers automated, closed-system cell isolation and processing equipment (Time Machine 3.0), standardized clinical protocols, and physician support infrastructure. Published clinical outcomes include peer-reviewed data on knee arthritis, lumbar back pain, neurodegenerative conditions, and safety profiles. CSN serves plastic surgeons, pain management specialists, sports medicine physicians, orthopedic surgeons, functional medicine practitioners, and anti-aging clinics with turnkey protocols and data-driven treatment guidance.